Vfend and blood bilirubin increased 
Vfend and blood bilirubin increased Patient Reports February 12, 2012
Vfend Side Effects Report #5061644-X
Vfend side effect was reported by a Physician from UNITED STATES on July 10, 2006. Female patient, 75 years of age, was diagnosed with systemic mycosis and was treated with Vfend. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood alkaline phosphatase increased, blood bilirubin increased, haematocrit decreased, haemoglobin decreased, prothrombin time prolonged, red blood cell count decreased. Vfend dosage: unknown. During the same period patient was treated with ZYVOX. Patient was hospitalized. Patient recovered.
Vfend Side Effects Report #5018330-1
Vfend side effect was reported by a Pharmacist from UNITED STATES on May 16, 2006. Female patient, 75 years of age, was diagnosed with systemic mycosis and was treated with Vfend. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood bilirubin increased, haematocrit decreased, haemoglobin decreased, prothrombin time prolonged, red blood cell count decreased, treatment noncompliance. Vfend dosage: unknown. During the same period patient was treated with ZYVOX. Patient was hospitalized. Patient recovered.
Vfend Side Effects Report #5097612-1
Vfend side effect was reported by a Physician from UNITED STATES on Aug 22, 2006. Female patient, 16 years of age, weighting 101.4 lb, was diagnosed with sinusitis fungal and was treated with Vfend. After drug was administered, patient experienced the following side effects: blood bilirubin increased, liver function test abnormal, malabsorption, pneumonia
. Vfend dosage: unknown. Patient was hospitalized. Patient recovered.Vfend Side Effects Report #5505656-8
Vfend side effect was reported by a Physician from JAPAN on Oct 22, 2007. Female patient, 48 years of age, was diagnosed with meningitis cryptococcal and was treated with Vfend. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood bilirubin increased, eyelid ptosis, jaundice
, rash . Vfend dosage: unknown. During the same period patient was treated with IMMUNOSUPPRESSIVE AGENTS. Patient was hospitalized. Patient recovered.Vfend Side Effects Report #4764786-9
Vfend side effect was reported by a Physician from JAPAN on Aug 25, 2005. Female patient, 45 years of age, was diagnosed with infection
and was treated with Vfend. After drug was administered, patient experienced the following side effects: blood bilirubin increased, multi-organ failure. Vfend dosage: 4 MG/KG BID, INTRAVENOUS; 2 MG/KG BID, INTRAVENOUS. Patient died on 08/21/2005.Vfend Side Effects Report #5131076-4
Vfend side effect was reported by a Physician from UNITED STATES on May 30, 2006. Female patient, 60 years of age, was diagnosed with fungal infection
and was treated with Vfend. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, jaundice cholestatic. Vfend dosage: unknown. During the same period patient was treated with ANTIBIOTICS. Patient recovered.Vfend Side Effects Report #4885958-9
Vfend side effect was reported by a Physician from JAPAN on Jan 05, 2006. Male patient, 59 years of age, weighting 138.9 lb, was diagnosed with fungal infection
, acute myeloid leukaemia and was treated with Vfend. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, liver disorder, pulmonary veno-occlusive disease, weight increased. Vfend dosage: 400 MG (2 IN 1 D), INTRAVENOUS. During the same period patient was treated with MYLOTARG, MICAFUNGIN, TIENAM, MIRIMOSTIM, STRONG NEO MINOPHAGEN C, CARBENIN, HABEKACIN. Patient was hospitalized. Patient recovered.Vfend Side Effects Report #4801065-5
Vfend side effect was reported by a Physician from JAPAN on Sept 29, 2005. Male patient, 71 years of age, was diagnosed with fungaemia and was treated with Vfend. After drug was administered, patient experienced the following side effects: blood bilirubin increased, blood creatine increased, blood urea increased, disseminated intravascular coagulation, hypoventilation, jaundice
, multi-organ failure, renal disorder, somnolence. Vfend dosage: 400 MG (200 MG). During the same period patient was treated with MICAFUNGIN. Patient was hospitalized. Patient died on 09/17/2005.Vfend Side Effects Report #4776588-8
Vfend side effect was reported by a Physician from JAPAN on Sept 02, 2005. Female patient, 58 years of age, was diagnosed with fungaemia and was treated with Vfend. After drug was administered, patient experienced the following side effects: blood bilirubin increased. Vfend dosage: unknown. Patient died on 01/01/2005.
Vfend Side Effects Report #4778606-X
Vfend side effect was reported by a Physician from JAPAN on Sept 12, 2005. Female patient, 58 years of age, was diagnosed with fungaemia and was treated with Vfend. After drug was administered, patient experienced the following side effects: blood bilirubin increased, cardiac failure. Vfend dosage: unknown. Patient died on 08/11/2005.
Vfend Side Effects Report #5044556-7
Vfend side effect was reported by a Physician from JAPAN on June 16, 2006. Female patient, 61 years of age, weighting 114.2 lb, was diagnosed with bronchopulmonary aspergillosis, pneumocystis jiroveci pneumonia, sedation, pain
and was treated with Vfend. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, disseminated intravascular coagulation, gamma-glutamyltransferase increased, hepatic function abnormal, pneumonia , respiratory disorder. Vfend dosage: 400 MG (200 MG, 2 IN 1 D), INTRAVENOUS. During the same period patient was treated with SULFAMETHOXAZOLE, DORMICUMECTION, LEPETAN, CARBENIN, MINOCYCLINE, ALENDRONATE, VIT K CAP, ZANTAC. Patient was hospitalized. Patient died on 05/17/2006.Vfend Side Effects Report #5045942-1
Vfend side effect was reported by a Physician from JAPAN on June 16, 2006. Female patient, 61 years of age, weighting 114.2 lb, was diagnosed with bronchopulmonary aspergillosis, pneumocystis jiroveci pneumonia, sedation, pain
and was treated with Vfend. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, condition aggravated, disseminated intravascular coagulation, gamma-glutamyltransferase increased, hepatic function abnormal, opportunistic infection. Vfend dosage: 400 MG (200 MG, 2 IN 1 D), INTRAVENOUS. During the same period patient was treated with SULFAMETHOXAZOLE, DORMICUMECTION, LEPETAN, CARBENIN, MINOCYCLINE, ALENDRONATE, VIT K CAP, ZANTAC. Patient was hospitalized. Patient died on 05/17/2006.Vfend Side Effects Report #5154514-X
Vfend side effect was reported by a Physician from JAPAN on Oct 31, 2006. Female patient, 59 years of age, weighting 109.1 lb, was diagnosed with bronchopulmonary aspergillosis and was treated with Vfend. After drug was administered, patient experienced the following side effects: blood bilirubin increased, gamma-glutamyltransferase increased, hepatic enzyme increased, inappropriate antidiuretic hormone secretion. Vfend dosage: unknown. During the same period patient was treated with TACROLIMUS, PROGRAF, PREDNISOLONE, MUCOSOLVAN, GASTROM, SULFAMETHOXAZOLE, HOKUNALIN. Patient recovered.
Vfend Side Effects Report #5191726-3
Vfend side effect was reported by a Physician from JAPAN on Dec 06, 2006. Female patient, 59 years of age, weighting 109.1 lb, was diagnosed with bronchopulmonary aspergillosis and was treated with Vfend. After drug was administered, patient experienced the following side effects: blood bilirubin increased, gamma-glutamyltransferase increased, inappropriate antidiuretic hormone secretion, liver disorder. Vfend dosage: 600 MG (200 MG, 2 IN 1 D) ORAL; 400 MG (200 MG, 2 IN 1 D) ORAL. During the same period patient was treated with TACROLIMUS, PROGRAF, PREDNISOLONE, MUCOSOLVAN, GASTROM, SULFAMETHOXAZOLE, HOKUNALIN. Patient recovered.
Vfend Side Effects Report #5288916-8
Vfend side effect was reported by a Health Professional from FRANCE on Apr 02, 2007. Male patient, 56 years of age, was diagnosed with bronchopulmonary aspergillosis and was treated with Vfend. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood bilirubin increased, gamma-glutamyltransferase increased, hepatosplenomegaly, jaundice
, pyrexia. Vfend dosage: unknown. During the same period patient was treated with CYTARABINE, VANCOMYCIN, ESOMEPRAZOLE MAGNESIUM, DIHYDROERGOTAMINE MESYLATE, CIPROFLOXACIN, PIPERACILLIN, PARACETAMOL, RITUXIMAB. Patient died on 06/23/2006.Vfend Side Effects Report #5750134-4
Vfend side effect was reported by a Consumer or non-health professional from FRANCE on May 15, 2008. Male patient, 35 years of age, was diagnosed with aspergillosis and was treated with Vfend. After drug was administered, patient experienced the following side effects: agitation, blood alkaline phosphatase increased, blood bilirubin increased, coma, confusional state, cytolytic hepatitis, gamma-glutamyltransferase increased, hypovolaemia. Vfend dosage: unknown. During the same period patient was treated with AZITHROMYCIN, PREDNISONE, SULFAMETHOXAZOLE, BROMAZEPAM. Patient was hospitalized. Patient recovered.
Vfend Side Effects Report #4701784-5
Vfend side effect was reported by a Consumer or non-health professional from on June 14, 2005. Female patient, child 11 years of age, weighting 97.00 lb, was diagnosed with aspergillosis, leukaemia and was treated with Vfend. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, back pain
, blood alkaline phosphatase increased, blood bilirubin increased, bronchopulmonary aspergillosis, flushing, headache . Vfend dosage: 200 MG (100 MG 2 IN 1 D) INTRAVENOUS; 300 MG (150 MG 2 IN 1 D INTRAVENOUS). During the same period patient was treated with ASPARGINASE, MERCAPTOPURINE, METHOTREXATE, VINCRISTINE. Patient was hospitalized. Patient recovered.Vfend Side Effects Report #5745716-X
Vfend side effect was reported by a Physician from FRANCE on May 14, 2008. Male patient was diagnosed with aspergillosis and was treated with Vfend. After drug was administered, patient experienced the following side effects: agitation, blood bilirubin increased, coma, confusional state, cytolytic hepatitis, gamma-glutamyltransferase increased, neurotoxicity, suicide attempt. Vfend dosage: unknown. Patient was hospitalized. Patient recovered.
Vfend Side Effects Report #5711728-5
Vfend side effect was reported by a Pharmacist from AUSTRALIA on Apr 09, 2008. Male patient, weighting 176.4 lb, was diagnosed with antifungal prophylaxis, evidence based treatment, pneumocystis jiroveci pneumonia and was treated with Vfend. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anion gap increased, blood albumin decreased, blood alkaline phosphatase increased, blood bicarbonate increased, blood bilirubin increased, blood calcium decreased, blood creatine phosphokinase decreased, blood creatinine increased. Vfend dosage: unknown. During the same period patient was treated with BACTRIM, VINCRISTINE, PREDNISOLONE. Patient recovered.
Vfend Side Effects Report #5146288-3
Vfend side effect was reported by a Physician from JAPAN on Oct 19, 2006. Male patient, 87 years of age, was treated with Vfend. After drug was administered, patient experienced the following side effects: aspergillosis, blood alkaline phosphatase increased, blood bilirubin increased, condition aggravated, gamma-glutamyltransferase increased, hepatic function abnormal, interstitial lung disease. Vfend dosage: 400 MG, INTRAVENOUS. During the same period patient was treated with PREDNISOLONE, IMMUNOSUPPRESSIVE AGENTS. Patient died on 10/01/2006.
Vfend Side Effects Report #5665007-5
Vfend side effect was reported by a Physician from JAPAN on Mar 03, 2008. Female patient, 27 years of age, was treated with Vfend. After drug was administered, patient experienced the following side effects: blood bilirubin increased, gamma-glutamyltransferase increased, prothrombin level decreased, pyrexia. Vfend dosage: DAILY DOSE:400MG. Patient recovered.
Vfend Side Effects Report #5717086-4
Vfend side effect was reported by a Physician from JAPAN on Apr 16, 2008. Female patient, 27 years of age, was treated with Vfend. After drug was administered, patient experienced the following side effects: blood bilirubin increased, gamma-glutamyltransferase increased, prothrombin level decreased, pyrexia. Vfend dosage: DAILY DOSE:400MG. Patient recovered.